Singapore markets closed

Galera Therapeutics, Inc. (GRTX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
0.2075+0.0248 (+13.57%)
At close: 04:00PM EDT
0.2075 0.00 (0.00%)
After hours: 07:52PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
0
Operating expenses
Research development
24,115
24,115
31,012
52,417
54,845
Selling general and administrative
22,836
22,836
20,214
20,951
15,708
Total operating expenses
46,951
46,951
51,226
73,368
70,553
Operating income or loss
-46,951
-46,951
-51,226
-73,368
-70,553
Interest expense
11,414
11,414
11,571
7,194
4,880
Total other income/expenses net
-2,312
-2,312
-1
-4
25
Income before tax
-59,082
-59,082
-62,292
-80,534
-74,234
Income tax expense
0
0
-70
0
-16
Income from continuing operations
-59,082
-59,082
-62,222
-80,534
-74,218
Net income
-59,082
-59,082
-62,222
-80,534
-74,218
Net income available to common shareholders
-59,082
-59,082
-62,222
-80,534
-74,218
Basic EPS
-1.88
-
-2.30
-3.12
-2.98
Diluted EPS
-1.88
-
-2.30
-3.12
-2.98
Basic average shares
37,914
-
27,087
25,789
24,870
Diluted average shares
37,914
-
27,087
25,789
24,870